BridgeBio Pharma News

Buy Rating Affirmed for BridgeBio Pharma on Acoramidis' Positive ATTR-CM Trial Outcomes

TipRanksApr 8 05:46 ET

Buy Rating Justified for BridgeBio Pharma Amidst Promising Long-Term Market Prospects for ATTR-CM Treatments

TipRanksMar 24 21:47 ET

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO) and Jazz Pharmaceuticals (JAZZ)

TipRanksMar 20 06:10 ET

BridgeBio Pharma Analyst Ratings

BenzingaMar 20 06:26 ET

Cantor Fitzgerald Adjusts Price Target on BridgeBio Pharma to $70 From $60, Maintains Overweight Rating

MT NewswiresMar 19 09:55 ET

BridgeBio Pharma Analyst Ratings

BenzingaMar 19 08:34 ET

Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $70

BenzingaMar 19 08:35 ET

BridgeBio Pharma Analyst Ratings

BenzingaMar 11 09:14 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: PepGen Inc. (PEPG), BridgeBio Pharma (BBIO) and Amedisys (AMED)

TipRanksMar 6 23:20 ET

BridgeBio Pharma Analyst Ratings

BenzingaMar 5 08:08 ET

Analysts Are Bullish on These Healthcare Stocks: BridgeBio Pharma (BBIO), Elevance Health (ELV)

TipRanksMar 5 05:12 ET

Maintained Buy Rating for BridgeBio Pharma Amidst Strategic Partnerships and Market Growth Potential

TipRanksMar 4 14:25 ET

Mizuho Securities Trims Price Target on BridgeBio Pharma to $53 From $60, Keeps Buy Rating

MT NewswiresMar 4 11:20 ET

TD Cowen Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

TipRanksMar 4 07:58 ET

BridgeBio Pharma Analyst Ratings

BenzingaMar 4 07:45 ET

Maintaining Hold on BridgeBio Pharma Amidst Bayer Partnership and Market Uncertainties

TipRanksMar 4 07:26 ET

Optimistic Buy Rating for BridgeBio Pharma Amid Strong Market Position and Promising Treatment Pipeline

TipRanksFeb 29 06:26 ET

Buy Rating Affirmed for BridgeBio Pharma on Strong Clinical Progress and Strategic Financial Positioning

TipRanksFeb 25 23:30 ET

BridgeBio Pharma Analyst Ratings

BenzingaFeb 23 11:28 ET

BridgeBio Pharma: Hold Rating Amidst Uncertainties in Product Launch and Market Dynamics

TipRanksFeb 23 07:29 ET